New Bayer® Migraine Formula Offers New OTC Choice to Ease Minds of Migraine Sufferers Everywhere

Consumers Encouraged to Access Coupon on and Try the Triple Action Power of Bayer Migraine Formula

MORRISTOWN, N.J., Sept. 4, 2012 /PRNewswire/ -- Bayer HealthCare's Consumer Care Division announced today the introduction of Bayer® Migraine Formula, an over-the-counter (OTC) medication designed to relieve migraine pain and accompanying symptoms - nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity). The powerful triple action formula of aspirin, acetaminophen and caffeine aims to target and alleviate tough migraine pain fast and effectively.  

(Logo: )

Bayer Migraine Formula will be a welcome addition to the pain relief aisle for migraine sufferers across America who have been affected by the OTC supply issues this year. The new formula contains the same three active ingredients and dosages for migraine relief as Excedrin® Migraine, which became unavailable earlier this year.

Beginning today, consumers can go to to get a $1 coupon to try Bayer Migraine Formula. Consumers can share the coupon with friends via Facebook or Twitter and triple the value of the coupon to $3 to try our new triple-action product[1].

"As a leader in OTC pain relievers worldwide, Bayer understands that consumers need different solutions for their different types of pain," said Reese Fitzpatrick, Director of Marketing, Bayer Aspirin. "Consumers have been extremely vocal about the lack of OTC options tough enough to target throbbing migraine pain. With Bayer Migraine Formula, we can offer an effective migraine solution that consumers desperately want and need."

Bayer Migraine Formula contains 250mg of aspirin, 250mg of acetaminophen and 65mg of caffeine. The combination of these three ingredients effectively treats migraine pain and accompanying symptoms - nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity). 

Available at major retailers nationwide, Bayer Migraine Formula will be packaged in a 50-count or 200-count bottle of coated caplets.

For more information about Bayer Migraine Formula or to receive your coupon, visit

About Bayer Migraine Formula

Bayer® Migraine Formula, an over-the-counter (OTC) medication designed to relieve migraine pain and accompanying symptoms - nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity). It contains a triple-action formula of aspirin (250mg), acetaminophen (250mg) and caffeine (65mg). Adults 18 and over should carefully follow the recommended dosage on the product label. Children under 18 years should consult a doctor prior to using Bayer Migraine Formula.

About Bayer

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2011, the Group employed about 112,000 people and had sales of euro 36.5 billion. Capital expenditures amounted to euro 1.7 billion, R&D expenses to euro 2.9 billion. For more information, go to

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.9 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec. 31, 2010) and is represented in more than 100 countries. Find more information at

The Consumer Care division of Bayer HealthCare is headquartered in Morristown, N.J. Bayer's Consumer Care division is among the largest marketers of over-the-counter medications and nutritional supplements in the world. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Bayer® Aspirin, Aleve®, Alka-Seltzer Plus®, Bactine®, RID®, Phillips'® Milk of Magnesia, Midol®, Alka-Seltzer®, One A Day® vitamins, and Flintstones™ vitamins in the United States, and, globally, Aspirin®, Flanax®/Apronax®, Talcid®, Rennie®, Canesten®, Bepanthen®, Bepanthol®, Supradyn®, Redoxon®, Berocca®, Cal-D-Vita/Elevit® and Vital 50 Plus®.


Jenny Winters, Tel. 646 500-7813                     

Anne Coiley, Tel. 973 254-4607   

[email protected]               

[email protected]

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.   

[1] To receive the $3 coupon, consumers must share the link to the coupon via either Facebook, Twitter or an Email to at least 5 friends. Maximum of 2 prints of each coupon per person. Both coupons expire 30 days from print. Coupons are good on 1 purchase of any Bayer Migraine Product.

SOURCE Bayer HealthCare

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

That didn’t take long. Sanofi CEO Paul Hudson has only been at the reins for a couple months, but on Tuesday, he unveiled a major shakeup.  

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.